Testosterone Use Among Women Rises Despite Limited Female-Specific Products

Women are increasingly seeking testosterone to manage menopause symptoms, with some obtaining male-formulated products through unconventional means due to lack of female alternatives. Testosterone, while typically associated with male development, plays important biological roles in women's bodies and naturally declines across the reproductive lifespan, though less dramatically than estrogen. Measuring female testosterone levels presents technical challenges, complicating efforts to establish normal ranges and understand the full scope of potential benefits or risks.

Testosterone naturally occurs in female bodies, produced by the ovaries and adrenal glands, though at concentrations roughly one-tenth to one-fifteenth of male levels. The hormone influences multiple biological systems beyond reproduction, including bone density, muscle function, cardiovascular health, and cognitive processes. Unlike the dramatic estrogen decline occurring at menopause, testosterone decreases gradually throughout a woman's life without a sharp drop at menopause.

Technical limitations in measuring such low hormone concentrations have historically prevented researchers from establishing reliable baseline ranges for women, complicating clinical assessment and treatment protocols. This measurement challenge remains a significant barrier to understanding testosterone's full effects and determining appropriate therapeutic dosing for female patients.